Filing Flows › Orthopediatrics (KIDS) › Q1 2026
Orthopediatrics (KIDS) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 1, 2026
Orthopediatrics (KIDS) reported revenue of $59.4M for the first quarter 2026 (Q1 2026), +13% from a year earlier and -4% from the quarter before. Operating margin was -14.0%, net loss $10.7M (18.0% of revenue).
Orthopediatrics, Q1 2026: revenue $59.4M (+13% year over year), operating margin -14.0%, net loss $10.7M, operating cash flow −$3.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $59.4M | -4% | +13% |
| Operating profit | −$8.3M | — | — |
| Net earnings | −$10.7M | — | — |
| Operating cash flow | −$3.3M | -132% | — |
What changed
Revenue was $59.4M in Q1 2026, up 13% year over year and down 4% from the previous quarter. Trauma and deformity was the largest line at 73% of revenue. Trauma and deformity added $5.2M year over year (up 14%), 74% of the total change. Sports medicine/other declined 1%.
Gross margin was 73.1%, up 0.1 points from Q1 2025. Operating costs exceeded revenue by $8.3M, an operating margin of -14.0%. Operating expenses grew 5% against revenue growth of 13%. The fastest-growing cost line was Sales & marketing (+11%). The quarter ended with a net loss of $10.7M, wider than the previous quarter's $10.1M loss.
Operating cash flow was −$3.3M. Non-cash charges added back $5.7M of depreciation and amortization and $4.0M of share-based compensation. Working capital and other items used $2.3M. Capital expenditures of $1.8M exceeded it, leaving free cash flow of −$5.0M.
Questions
What was Orthopediatrics' revenue in the first quarter 2026?
Orthopediatrics (KIDS) reported revenue of $59.4M for the first quarter 2026 (Q1 2026), +13% from a year earlier and -4% from the quarter before.
Was Orthopediatrics profitable in the first quarter 2026?
Operating loss was $8.3M (-14.0% of revenue) and net loss $10.7M.
Source: Orthopediatrics 10-Q on SEC EDGAR.